High-sensitivity detection of trace amounts of c-erbB-2 oncogene was reported to be equal to or surpass the ability of CA 15-3 for early diagnosis and/or follow-up recurrent screening of breast cancer. Therefore, in the current study, by using upconversion nanoparticles (UCNPs), rare earth-doped NaYF4:Yb(3+)/Er(3+) as the luminescent labels, a upconversion luminescent (UCL) biosensor based on dual-signal amplification of exonuclease III (ExoIII)-assisted target cycles and long-range self-assembly DNA concatamers was developed for the detection of c-erbB-2 oncogene. The proposed biosensor exhibited ultrasensitive detection with limit as low as 40 aM, which may express the potential of being used in trace analysis of c-erbB-2 oncogene and early diagnosis of breast cancer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838860 | PMC |
| http://dx.doi.org/10.1038/srep24813 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Combined Clinical Diagnosis of TNF-, TSH, and p185 Protein in Breast Cancer.
J Oncol
June 2022
Thyroid and Breast Dept 1, Extra-Thyroid and Breast Neoplasms 1, Cangzhou Central Hospital, Cangzhou, China.
Objective: To study the concentrations of tumor necrosis factor (TNF-), thyroid-stimulating hormone (TSH), and c-erbB-2 oncogene protein product P185 in different pathological stages of breast cancer and to analyze their combined clinical diagnosis of breast cancer significance.
Methods: 67 breast cancer patients who were treated in our hospital from January 2018 to September 2020 were set as the breast cancer group and were divided into stages I, II, III, and IV according to clinicopathology. In addition, 55 patients with benign breasts who were admitted to the hospital at the same time were selected as the benign breast group, and 60 healthy people in our hospital during the same period were selected as the healthy group.
Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activation.
J Cardiothorac Surg
July 2021
Cardiothoracic surgery department, Heping Hospital Affiliated to Changzhi Medical College, No. 110 Yan'an South Road, Luzhou District, Changzhi, 046000, Shanxi, China.
Objective: C-erbB-2 has been confirmed to be an oncogene that participates in cell growth, differentiation and division of tumors. We are wondered if its silenced expression can exert an anti-tumor effect. Therefore, this study is conducted to investigate the mechanism of C-erbB-2 silencing and IGF-1 pathway on esophageal carcinoma (EC) cell biological behaviors.
View Article and Find Full Text PDFAnalysis of the DOK1 gene in breast cancer.
Mol Biol Rep
March 2020
Department of Medical Biology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Kocamustafapasa, 34098, Istanbul, Turkey.
Breast cancer, which is the most common type of cancer among women, is a heterogenous disease. It results from progressive accumulation of genetic and epigenetic alterations in different genes. The Dok1 protein has been identified as the major substrate of protein tyrosine kinases in hematopoietic cells.
View Article and Find Full Text PDFEvaluation of the expression of the oncogen C-ERBB-2/HER2 in advanced gastric cancer cases from Costa Rica.
Ecancermedicalscience
September 2019
Center for Research in Microscopic Structures (CIEMIC), University of Costa Rica, 11501-2060 San José, Costa Rica.
Justification: The prevalence of gastric cancer (GC) with increased expression of the HER2 oncoprotein shows important variations worldwide. Incidence and mortality rates of GC in Costa Rica are among the highest in Latin America and the world; however, the prevalence of HER2-positive cases in this country is unknown. Evaluation of this parameter is important to decide the therapeutic approach for GC patients.
View Article and Find Full Text PDFUltrasound microbubble-mediated CRISPR/Cas9 knockout of C-erbB-2 in HEC-1A cells.
J Int Med Res
May 2019
1 Key Laboratory of Cell and Molecular Genetic Translational Medicine in Hainan Province, Hainan General Hospital/Affiliated Hainan Hospital of Jinan University, No.19 Xiuhua Road, Haikou City, Hainan Province, China.
Objective: Epidermal growth factor receptor 2 (C-erbB-2) is one of the most frequently mutated oncogenes in human tumors. We aimed to evaluate the knockout efficiency of clustered regularly interspaced short palindromic repeat (CRISPR) technology using ultrasound microbubble transfection to target C-erbB-2 in human endometrial cancer (HEC)-1A cells.
Methods: Three single guide RNAs (sgRNAs) targeting C-erbB-2 were designed and used to construct CRISPR/CRISPR-associated (Cas)9-C-erbB-2 plasmids.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!